• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN CALIBRATORS; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN CALIBRATORS; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6801043
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/24/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation confirmed lower than expected vitros myoglobin quality control results were obtained using a non-vitros quality control fluid in combination with two different reagent lots on two different vitros 5600 integrated systems.A definitive assignable cause of the event could not be determined.Multiple precision tests performed indicated that the vitros 5600 systems were performing as intended.The lower than expected vitros myog quality control results were reproducible across two vitros 5600 systems, therefore, an instrument related issue did not likely contribute to the event.An unknown issue related to the cliniqa controls in use, or the vitros myog reagent or calibrators could not be ruled out as contributing to the event.Additionally, improper fluid handling of the calibrators or cliniqa control fluids could not be ruled out as contributing to the event.A definitive assignable cause of the event could not be determined.
 
Event Description
A customer obtained lower than expected vitros myoglobin quality control results using a non-vitros quality control fluid in combination with two different reagent lots on two different vitros 5600 integrated systems.Vitros myoglobin reagent lot 1365: cliniqa lot 1804042 l1 results of 54.5, 54.5, 53.9, 54.3, 53.1, 54.5, 52.9, 53.9, 53.3, 53.2, 53.0, 53.8, 53.8, 54.8, 55.0, 53.5, 55.0, 53.5, 53.4, 53.5, 53.7, 54.1, 54.2, 53.4, 52.6, 52.5, 53.7, 51.4, 52.2, 52.6, 51.9, 51.5, 52.5, 52.7, 54.3, 54.6, 53.6, 50.8, 51.1, 51.6, 51.0, 51.0, 51.4, 51.8, 51.0, 51.1, 52.0, 52.1, 52.8, 52.6, 52.4, 51.5, 52.6, 50.3, 51.0, 52.2, 51.4, 50.1, 52.1, 52.1, 50.6, 50.7, 50.9, 50.7, 51.2, 51.0, 51.4, 49.9, 50.6, 51.1, 51.2, 50.3, and 50.5 ng/ml vs.The expected result of 65.1 ng/ml.Vitros myoglobin reagent lot 1375: cliniqa lot 1804042 l1 results of 53.6, 54.3, 53.4, 51.6, 51.6, 51.1, 51.4, 50.6, 51.8, 50.0, 50.7, 50.3, 50.6, 49.9, 50.5, 50.4, 50.6, 51.6, 52.7, 52.1, 53.0, 51.6, 51.6, 52.5, 52.6, 53.4, 53.7, 53.1, 53.5, 52.8, 53.1, 53.3, 54.2, and 53.0 ng/ml vs.The expected result of 65.1 ng/ml.Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The lower than expected vitros myoglobin results were generated from a non-patient fluid, however the investigation cannot conclude that patient sample results would not be affected if the event were to recur undetected.Ortho has not been made aware of allegation of actual patient harm as a result of the event.This report is number four of four mdr¿s for this event.Four 3500a forms are being submitted for this event as four devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho).Complaint numbers (b)(4).
 
Manufacturer Narrative
The actual product impacted by this event is the vitros immunodiagnostics products myoglobin calibrators, not the vitros immunodiagnostic products myoglobin reagent pack.Therefore, the brand name, common device name, catalogue # and unique device identifier have been corrected.Investigation into the root cause is still in progress, but the issue is linked to the stability of the vitros myoglobin calibrators post reconstitution by the user.Ortho has issued field action with the following instructions to the end user.Reconstitute the calibrators using 1.0 ml distilled water, as per current instructions.Allow reconstituted calibrator vials to stand at room temperature for 2 hours and then proceed with calibration within 2 hours (4 hours total).Discard reconstituted calibrators after 4 hours.Ortho notified the fda¿s new york district office of this field action on 30 november 2018.
 
Event Description
This report corresponds to ortho clinical diagnostics inc (ortho).Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN CALIBRATORS
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
MDR Report Key7994409
MDR Text Key126373133
Report Number3007111389-2018-00163
Device Sequence Number1
Product Code JIS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 12/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/13/2019
Device Catalogue Number6801043
Device Lot Number1375
Was Device Available for Evaluation? Yes
Date Manufacturer Received09/24/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-